Biosyent Company Insiders
| RX Stock | CAD 11.20 0.05 0.45% |
Biosyent employs about 6 people. The company is managed by 6 executives with a total tenure of roughly 19 years, averaging almost 3.0 years of service per executive, having 1.0 employees per reported executive. Recap of Biosyent's management performance can provide insight into the venture performance.
| Robert March President CFO, Senior Vice President - Finance |
Biosyent |
Biosyent Management Team Effectiveness
The company has return on total asset (ROA) of 0.1191 % which means that it generated a profit of $0.1191 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1977 %, meaning that it created $0.1977 on every $100 dollars invested by stockholders. Biosyent's management efficiency ratios could be used to measure how well Biosyent manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to climb to 0.15 in 2025. Return On Capital Employed is likely to climb to 0.20 in 2025. At this time, Biosyent's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to climb to about 6.8 M in 2025, whereas Other Current Assets are likely to drop slightly above 163.3 K in 2025.Common Stock Shares Outstanding is likely to drop to about 13.5 M in 2025. Net Income Applicable To Common Shares is likely to drop to about 4.8 M in 2025
Biosyent Workforce Comparison
Biosyent is currently under evaluation in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 1,450. Biosyent adds roughly 0.0 in number of employees claiming only tiny portion of equities under Health Care industry.
Biosyent Profit Margins
The company has Profit Margin (PM) of 0.21 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.29 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.29.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.56 | 0.73 |
|
|
Biosyent Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Biosyent Price Series Summation is a cross summation of Biosyent price series and its benchmark/peer.
Biosyent Notable Stakeholders
A Biosyent stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Biosyent often face trade-offs trying to please all of them. Biosyent's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Biosyent's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Robert March | CFO, Senior Vice President - Finance | Profile | |
| Neelu Atwal | Director Resources | Profile | |
| Alfred DSouza | Advisor | Profile | |
| Ren Goehrum | CEO Chairman | Profile | |
| Joost Mark | Vice Development | Profile | |
| Kevin Wilson | Vice Sales | Profile |
About Biosyent Management Performance
The success or failure of an entity such as Biosyent often depends on how effective the management is. Biosyent management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Biosyent management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Biosyent management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.14 | 0.15 | |
| Return On Capital Employed | 0.19 | 0.20 | |
| Return On Assets | 0.14 | 0.15 | |
| Return On Equity | 0.17 | 0.18 |
Please note, the imprecision that can be found in Biosyent's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Biosyent. Check Biosyent's Beneish M Score to see the likelihood of Biosyent's management manipulating its earnings.
Biosyent Workforce Analysis
Traditionally, organizations such as Biosyent use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Biosyent within its industry.Biosyent Manpower Efficiency
Return on Biosyent Manpower
| Revenue Per Employee | 5.3M | |
| Revenue Per Executive | 5.3M | |
| Net Income Per Employee | 1.1M | |
| Net Income Per Executive | 1.1M | |
| Working Capital Per Employee | 5.1M | |
| Working Capital Per Executive | 5.1M |
Additional Tools for Biosyent Stock Analysis
When running Biosyent's price analysis, check to measure Biosyent's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biosyent is operating at the current time. Most of Biosyent's value examination focuses on studying past and present price action to predict the probability of Biosyent's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biosyent's price. Additionally, you may evaluate how the addition of Biosyent to your portfolios can decrease your overall portfolio volatility.